Screener/Healthcare/Biotechnology

IBRX

ImmunityBio, Inc.NASDAQ
$7.39-2.01 (-21.38%)
Mid CapUnder $10HealthcareFastest GrowingHigh ROE
$1.83
$12.43
$6.54
$9.15
EPS (TTM)$-0.38
P/E Ratio—
Dividend Yield—
Market Cap$9.07B
Volume82.69M
Prev Close$9.40
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$38.3M-$62.0M$-0.0699.0%-161.8%
Q3 '25$32.1M-$67.3M$-0.0799.4%-209.8%
Q2 '25$26.4M-$92.6M$-0.1099.5%-350.3%
Q1 '25$16.5M-$129.7M$-0.1599.6%-785.0%
Q3 '24$6.1M-$85.8M$-0.14—-1404.4%
Q2 '24$1.0M-$134.6M$-0.20—-12854.3%
Q1 '24$40K-$134.1M$-0.20—-335325.0%
Q4 '23$139K-$233.4M$-0.38—-167923.7%
Get Your Daily Market Recap